Digital Patient Journey Solution for Patients Undergoing Elective Hip and Knee Arthroplasty Dueto Primary Osteoarthritis

VTT Technical Research Centre of Finland

Status: Completed

Conditions: Primary Elective Total Knee Arthroplasty (TKA); Primary Elective Hip Arthroplasty (THA)

Treatments: Device: Digital Patient Journey Solution

Study type: Interventional

Funder types: Other

Identifiers

NCT04083326

Icory

Details and patient eligibility

About

This is an interventional study which aims at assessing the effects of a digital patient journey solution in patients undergoing elective hip and knee arthroplasty due to primary osteoarthritis.

Full description

Traditionally, pre- and postoperative education has been provided face-to-face by paper-based methods for patients undergoing total hip arthroplasty (THA) and total knee arthroplasty (TKA). Digital patient journey solution has potential to enhance adherence to preoperative preparation and postoperative rehabilitation, and further improve patient experience, while reducing potential adverse events.

The purpose of this study is to assess a digital patient journey solution developed for patients undergoing elective hip and knee arthroplasty. The digital solution aims to support patient's preparation to and recovery from a hip and knee arthroplasty through provision of timely information and support related to preoperative preparation and postoperative rehabilitation. The information on the application is aligned with the patient's individual needs and requirements, and contains exercises to be completed daily for the duration of the program.

Enrollment: 69 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18 years or older
• Undergoing primary elective total hip or knee arthroplasty
• Diagnosis of primary osteoarthritis of hip or knee (M16.0, M16.1, M17.0, M17.1)
• Ability to speak, read and understand Finnish
• Access to a web-based device

Exclusion criteria

• Undergoing a total hip or knee arthroplasty revision
• A bilateral total hip or knee arthroplasty
• Total hip or knee arthroplasty following a rheumatoid arthritis
• Inability to walk with use of walking aids
• Unable to see or hear that impede the use of the digital patient journey solution

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

69 participants in 2 patient groups

Digital Patient Journey Solution

Experimental group

Description:

Patients in the intervention arm are provided with a digital patient journey solution used on a mobile device. The application is intended to be used during the whole care path. The patient can familiarize him-/herself to the phases of care through visual timeline representation of the care path, get information on how to prepare for a surgery, receive reminders, fill in questionnaire forms, communicate with the care personnel via messaging functionality and video calls, and search information from frequently asked questions. The application contains information about the preparation, forms for anamnesis, anesthesia and treatment follow-up, information videos and pictures, and timely and individually-tailored reminders, e.g., on when to stop eating and drinking before the surgery. In addition, the application provides instructions on how to arrive to the treatment unit and comprehensive guidance for wound care and rehabilitation at home after the operation.

Treatment:

Device: Digital Patient Journey Solution

Conventional care group

No Intervention group

Description:

Conventional care consists of specialist assessment in conjunction with pre-operative surgical visits and patient education. Patients in the conventional care group are provided with pre- and postoperative information face-to-face by paper-based method. Patients will be admitted and mobilised on the day of the surgery, and discharged one to three days after surgery. The follow-up visit, conducted by a physiotherapist, is conducted after 6 to 8 weeks post-discharge for patients with TKA and after 8 to 12 weeks for patients with THA.